Hypercholesterolemia: its impact on ischemia-reperfusion injury
Related Experiment Video
Updated: Aug 14, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Karen Y Stokes1, D Neil Granger
1Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA. kstoke@lsuhsc.edu
Insights
High cholesterol (hypercholesterolemia) worsens ischemia reperfusion injury by promoting inflammation and blood clotting in blood vessels. Targeting these pathways may help treat cardiovascular disease.
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Pathophysiology
Background:
- Ischemic diseases, including those caused by atherosclerosis, are a primary global cause of mortality.
- Hypercholesterolemia is a significant risk factor for atherosclerosis and is linked to a higher incidence of ischemia reperfusion.
- Elevated cholesterol levels worsen vascular responses to ischemia-reperfusion, intensifying organ dysfunction.
Purpose of the Study:
- To explore the link between hypercholesterolemia and ischemia reperfusion injury.
- To identify common inflammatory and prothrombotic pathways involved in both conditions.
- To highlight potential therapeutic targets for cardiovascular disease.
Main Methods:
- The study reviews the pathophysiology of atherosclerosis and hypercholesterolemia.
- It examines the vascular responses during ischemia-reperfusion.
- It focuses on the role of inflammation, endothelial dysfunction, and specific molecular pathways.
Main Results:
- Hypercholesterolemia exacerbates ischemia-reperfusion injury and organ dysfunction.
- Common mechanisms include a proinflammatory and prothrombotic microvasculature.
- Endothelial dysfunction involves leukocyte/platelet recruitment, oxidative stress, and angiotensin II receptor Type 1a activation.
Conclusions:
- Shared inflammatory pathways in ischemia-reperfusion injury and hypercholesterolemia present therapeutic targets.
- Developing drugs targeting these pathways could combat cardiovascular disease and ischemic disorders.
- Understanding these mechanisms is crucial for advancing treatment strategies.
Abstract:
Ischemic diseases are a leading cause of death worldwide. It is becoming increasingly appreciated that atherosclerosis is a major cause of ischemia reperfusion. Hypercholesterolemia is a major risk factor for the development of atherosclerosis, and is associated with an increased incidence of ischemia reperfusion. Furthermore, elevated cholesterol levels exacerbate the vascular responses to ischemia-reperfusion, which intensifies the resulting organ dysfunction. One of the underlying features of both ischemia-reperfusion injury and hypercholesterolemia is the proinflammatory and prothrombogenic phenotype invoked in the microvasculature. This is manifested as an endothelial dysfunction, characterized by leukocyte and platelet recruitment, oxidative stress and angiotensin II receptor Type 1a activation. These common pathways of inflammation offer attractive targets for the development of drugs to combat cardiovascular disease and the associated ischemic disorders.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cholecystitis
Coronary Artery Disease II: Pathophysiology

